PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 42 filers reported holding PLX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,371 | -20.7% | 41,285 | 0.0% | 0.00% | – |
| Q4 2022 | $6,775 | -74.9% | 41,285 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | -73.0% | 41,285 | 0.0% | 0.00% | – |
| Q2 2022 | $100,000 | -47.4% | 41,285 | -12.0% | 0.00% | – |
| Q1 2022 | $190,000 | -51.0% | 46,925 | -3.2% | 0.00% | – |
| Q4 2021 | $388,000 | -53.1% | 48,462 | +13.0% | 0.00% | – |
| Q3 2021 | $827,000 | +34.7% | 42,869 | -3.7% | 0.00% | – |
| Q2 2021 | $614,000 | +89.5% | 44,513 | +23.9% | 0.00% | – |
| Q1 2021 | $324,000 | +489.1% | 35,932 | +257.8% | 0.00% | – |
| Q4 2020 | $55,000 | +120.0% | 10,043 | -8.5% | 0.00% | – |
| Q1 2020 | $25,000 | -47.9% | 10,980 | 0.0% | 0.00% | – |
| Q4 2019 | $48,000 | -15.8% | 10,980 | -0.2% | 0.00% | – |
| Q3 2019 | $57,000 | -28.8% | 11,003 | -0.9% | 0.00% | – |
| Q2 2019 | $80,000 | +35.6% | 11,103 | 0.0% | 0.00% | – |
| Q1 2019 | $59,000 | – | 11,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |